PRINCIPLE OF THE ASSAY
This assay employs the quantitative indirect enzyme immunoassay technique. Recombinant SARS-CoV-2 Nucleocapsid (NP) has been pre-coated onto a microplate. Standards or samples are pipetted into the wells and any Anti-SARS-CoV-2 Nucleocapsid (NP) Human IgA present is bound by the immobilized protein. After washing away any unbound substances, a biotin-labeled Mouse Anti-Human IgA antibody is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Anti-SARS-CoV-2 Nucleocapsid (NP) Human IgA bound in the initial step. The color development is stopped and the intensity of the color is measured.
Stability and Storage | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃. |
Detection method | Colorimetric |
Sample type | Plasma, Serum |
Assay type | Quantitative |
Sensitivity | 0.5 ng/mL |
Range | 0.625 - 40 ng/mL |
Recovery | 80-120% |
Background | |
Alternative Names | |
Shipping | 2-8 ℃ |
Specifications | Nucleocapsid |
Note | For Research Use Only. |